PropertyValue
?:abstract
  • Recommendation provides information to employees of medical departments at any level and primarily primary care about the possible proarrhythmic and adverse effects of drugs used for the treatment of COVID-19 patients and the features of therapy for COVID-19 patients with heart rhythm and conduction disorders receiving permanent antiarrhythmic therapy
  • Recommendation provides information to employees of medical departments at any level and primarily primary care about the possible proarrhythmic and adverse effects of drugs used for the treatment of COVID-19 patients and the features of therapy for COVID-19 patients with heart rhythm and conduction disorders receiving permanent antiarrhythmic therapy.
is ?:annotates of
?:creator
?:journal
  • Kardiologiia
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • [Recommendations for the management of COVID 19 patients regarding proarrhythmic effects of some current treatments, specifically if these patients suffer from arrhythmias, and for those receiving antiarrhythmic therapy.]
?:type
?:who_covidence_id
  • #1005230
  • #940620
?:year
  • 2020

Metadata

Anon_0  
expand all